当前位置:
X-MOL 学术
›
Lancet Respir. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pound foolish and penny wise—when will dosing of rifampicin be optimised?
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2018-01-29 , DOI: 10.1016/s2213-2600(18)30044-4 Cecile Magis-Escurra , Richard M Anthony , Adri G M van der Zanden , Dick van Soolingen , Jan-Willem C Alffenaar
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2018-01-29 , DOI: 10.1016/s2213-2600(18)30044-4 Cecile Magis-Escurra , Richard M Anthony , Adri G M van der Zanden , Dick van Soolingen , Jan-Willem C Alffenaar
In September, 2017, the authors attended a tuberculosis conference in China where it became clear that resistance to anti-tuberculosis drugs could render the ambitious WHO targets for tuberculosis elimination unreachable.
更新日期:2018-03-24